Cloning and characterization of the 5'-flanking sequence for the human DNA topoisomerase II beta gene

S W Ng1, Y Liu, L E Schnipper

  • 1Hematology/Oncology Division, Harvard Institutes of Medicine, Beth Israel Deaconess Medical Centre, East Campus, Boston, MA 02215, USA.

Gene
|January 13, 1998
PubMed

Insights

Investigating human topoisomerase IIbeta gene expression, this study identified key regulatory regions in its 5'-flanking sequence. These findings are crucial for understanding drug resistance mechanisms in cancer therapy.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Mammalian cells possess two type II DNA topoisomerase isoforms, critical targets for numerous anticancer drugs.
  • Cellular sensitivity to topoisomerase II-targeting drugs is significantly influenced by the expression levels of these isozymes.

Purpose of the Study:

  • To explore the coordinated expression of topoisomerase II isoforms.
  • To elucidate the regulatory mechanisms governing gene expression in the context of drug resistance.
  • To clone and characterize the 5"-flanking sequence of the human topoisomerase IIbeta gene.

Main Methods:

  • Cloning and characterization of the 5"-flanking sequence of the human topoisomerase IIbeta gene.
  • Analysis of transcriptional start sites and GC content.
  • Transient expression assays with 5"- and 3"-deletions.
  • Gel mobility shift studies to identify protein-DNA interactions.

Main Results:

  • The 5"-flanking region of the topoisomerase IIbeta gene exhibits high GC content and lacks a TATA box, with two distinct transcriptional start sites.
  • Limited sequence homology exists between the 5"-flanking regions of topoisomerase IIbeta and topoisomerase IIalpha genes.
  • Deletion analyses identified critical regions for transcriptional regulation, including sequences within the first intron that enhance promoter activity.
  • Nuclear protein factors specifically bind to downstream elements, suggesting a role in transcriptional regulation.

Conclusions:

  • The study delineates regulatory elements controlling human topoisomerase IIbeta gene expression.
  • Understanding these mechanisms is vital for developing strategies to overcome drug resistance in cancer treatment.
  • The findings contribute to the broader understanding of topoisomerase II gene regulation and its implications in oncology.

Related Concept Videos

DNA Helicases00:55

DNA Helicases

DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...